Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø ¹× °æÀï ºÐ¼®(-2030³â)
Cloning and Mutagenesis Market Report: Trends, Forecast and Competitive Analysis to 2030
»óǰÄÚµå : 1560294
¸®¼­Ä¡»ç : Lucintel
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 7,017,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,800 £Ü 8,392,000
PDF (2 Users License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 2¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,700 £Ü 9,694,000
PDF (5 Users License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,850 £Ü 12,805,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ ±â¾÷ ³» ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß µ¿Çâ°ú ¿¹Ãø

¼¼°è Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö 18.0%ÀÇ CAGR·Î 2030³â±îÁö ¾à 70¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ¸¸¼º ¹× À¯Àü¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ±â¼úÀÇ Ã¤Åà Ȯ´ë, °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù. Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ¼¼°è ½ÃÀåÀÇ ¹Ì·¡´Â ¹ÙÀÌ¿À Á¦¾à ¹× Á¦¾à»ç, CRO ¹× CMO, Çмú ¹× ¿¬±¸ ±â°ü ½ÃÀå¿¡ ±âȸ°¡ ÀÖ´Â À¯¸ÁÇÑ ½ÃÀåÀ¸·Î Æò°¡µÇ°í ÀÖ½À´Ï´Ù.

LucintelÀº À¯ÀüÀÚ Ä¡·á, À¯ÀüÀÚ ºÐ¼®, ¹ÙÀÌ¿ÀÀǾàǰ µî ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ Ŭ·Ð ŰƮÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È¿¡µµ Ŭ·Ð ŰƮ°¡ ´õ Å« ºÎ¹®À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù.

¹ÙÀÌ¿ÀÀǾàǰ ¹× Á¦¾àȸ»ç´Â Áúº´ È®»êÀÇ Áõ°¡·Î ÀÎÇØ ÀÌ ½ÃÀå¿¡¼­ °¡Àå Å« ºÎ¹®À¸·Î ³²À» °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ºÏ¹Ì´Â »ý¸í°øÇÐ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ÁÖ¿ä ±â¾÷ÀÇ Á¸Àç·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« Áö¿ªÀ¸·Î ³²À» °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀåÀÇ »õ·Î¿î Æ®·»µå

Ŭ·ÐÈ­ ¿¬±¸¿Í ±× »ó¾÷È­´Â ±â¼ú ¹ßÀü, ½ÃÀå ¼ö¿äÀÇ º¯È­, ±×¸®°í ÀÌ·¯ÇÑ Ãß¼¼¸¦ º¯È­½ÃŰ´Â ±ÔÁ¦¿¡ ÀÇÇØ ºü¸£°Ô º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â º¹Á¦/µ¹¿¬º¯ÀÌÀ¯¹ßÀÌ Á¶»ç ¶Ç´Â °³¹ß ¸ñÀûÀ¸·Î ¾î¶² ¹æÇâÀ¸·Î ³ª¾Æ°¥Áö °áÁ¤ÇÏ´Â ºÐ¾ß Áß ÀϺÎÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ ÀÌÇØÇϸé, ÀÌ ½ÃÀåÀÌ ¾ÕÀ¸·Î ¾î¶² ¹æÇâÀ¸·Î ³ª¾Æ°¥Áö, ±×¸®°í ±× µµÀü°úÁ¦´Â ¹«¾ùÀÎÁö¿¡ ´ëÇØ º¸´Ù ¸íÈ®ÇÑ ±×¸²À» ±×¸± ¼ö ÀÖ½À´Ï´Ù.

Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀåÀº À¯ÀüÀÚ ÆíÁý ±â¼úÀÇ Áõ°¡, AI¿Í ¸Ó½Å·¯´×ÀÇ ÅëÇÕ, °³ÀÎ ¸ÂÃãÇü ÀÇ·áÀÇ ¼ºÀå, ±ÔÁ¦ °ü¸®»Ó¸¸ ¾Æ´Ï¶ó À±¸®Àû ¹®Á¦¿¡ ´ëÇÑ °­Á¶, ½ÅÈï ½ÃÀåÀ¸·ÎÀÇ È®Àå µîÀÇ Ãß¼¼·Î ÀÎÇØ Å« º¯È­¸¦ °Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â Çõ½ÅÀ» ÃËÁøÇϰí, ÀÀ¿ë ÇÁ·Î±×·¥ ¼±ÅÃÀ» È®´ëÇϸç, ½ÃÀå ¿ªÇп¡ ¿µÇâÀ» ¹ÌÄ¡¸é¼­ Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ßÀÌ ÁøÈ­ÇÏ´Â ¹æ½ÄÀ» ÀçÁ¤ÀÇÇϰí ÀÖ½À´Ï´Ù. µû¶ó¼­, ÁÖ¿ä ÀÌÇØ°ü°èÀÚµéÀº ÀÌ·¯ÇÑ Æ®·»µå¸¦ Áö¼ÓÀûÀ¸·Î ÆÄ¾ÇÇÏ¿© º¯È­ÇÏ´Â À¯ÀüÇÐ ¿¬±¸ ¹× »ý¸í°øÇÐ ºÐ¾ß¿¡¼­ »õ·Î¿î ±âȸ¸¦ âÃâÇÒ ¼ö ÀÖ´Â ¼ö´ÜÀ¸·Î Ȱ¿ëÇÏ´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù.

Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀåÀÇ ÃÖ±Ù µ¿Çâ

ÃÖ±ÙÀÇ µ¿ÇâÀº Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ºÐ¾ß¿¡¼­ °ý¸ñÇÒ ¸¸ÇÑ ±â¼úÀû Áøº¸¸¦ º¸¿´°í, ÀÌ¿¡ µû¶ó ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°¡ ÁøÈ­ÇÏ¿© ´Ù¾çÇÑ »ê¾÷ ºÐ¾ß¿¡¼­ µµÀÔÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ±× °á°ú, º¹Á¦°¡ ´Ü¼øÇÑ ÇмúÀû ¿¬±¸¿´´ø ½Ã´ë¿¡¼­ À¯ÀüÀÚ ¿¬±¸°¡ Å©°Ô ¹ßÀüÇßÀ½À» ¾Ë ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ ½ÅÈï±¹ ½ÃÀåÀÇ °³Ã´À» ÀÌÇØÇϸé ÇöÀç ½ÃÀåÀ» ¿òÁ÷ÀÌ´Â ¿øÀÎÀÌ ¹«¾ùÀÎÁö ¾Ë ¼ö ÀÖ½À´Ï´Ù.

À¯ÀüÀÚ ÆíÁý µµ±¸ÀÇ °³¹ß, ÇÕ¼º»ý¹°ÇÐ ¿¬±¸ °³¹ß, À¯Àüü µ¥ÀÌÅͺ£À̽ºÀÇ È°¿ë È®´ë, »õ·Î¿î ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, °øµ¿ ¿¬±¸ ±âȸ µîÀº Ãֱ٠Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀå µ¿ÇâÀÇ ÀϺÎÀ̸ç, ÇâÈÄ ¹æÇ⼺À» Çü¼ºÇÒ »Ó¸¸ ¾Æ´Ï¶ó À¯ÀüÇÐ ¿¬±¸ Ȱµ¿¿¡µµ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ½ÅÈï ½ÃÀå °³Ã´Àº Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ±â¼úÀÇ Àû¿ë ¹üÀ§¸¦ ³ÐÈ÷°í ½ÃÀå ¿ªÇп¡ ¿µÇâÀ» ¹ÌÄ¡¸é¼­ ±â¼ú Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀå¿¡¼­ÀÇ Àü·«Àû ¼ºÀå ±âȸ

±â¼úÀÇ ¹ßÀü, ÀÀ¿ë ºÐ¾ßÀÇ Áõ°¡, ½ÃÀå ¼ö¿äÀÇ º¯È­´Â Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß »ê¾÷¿¡¼­ Àü·«Àû ¼ºÀå ±âȸ¸¦ ÃËÁøÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Àü¸ÁÀ» ÀνÄÇÏ¸é ±â¼ú Çõ½ÅÀ» ÃËÁøÇÏ°í ´Ù¾çÇÑ Àå¾Ö¹°À» ÇØ°áÇÏ¿© ¿µ¿ªÀ» È®ÀåÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. »óÀ§ Æ´»õ ºÐ¾ß¿Í Æ®·»µå¿¡ ÁÖ¸ñÇÔÀ¸·Î½á ±â¾÷°ú ¿¬±¸ÀÚµéÀº Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ºÐ¾ßÀÇ ºñ¾àÀûÀÎ ÀáÀç·ÂÀ» Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀåÀÇ Àü·«Àû ¼ºÀå ±âȸ¿¡´Â ³ó¾÷ »ý¸í°øÇÐ, °³ÀÎ ¸ÂÃãÇü ÀÇ·á, Àç»ý ÀÇÇÐ, ÀǾàǰ °³¹ß ¹× ¹ß°ß, ȯ°æ ¹× »ê¾÷ ÀÀ¿ë ºÐ¾ß°¡ Æ÷ÇԵ˴ϴÙ. ÀÌÇØ°ü°èÀÚµéÀº Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ßÀÇ ¼ºÀå ±âȸ¸¦ Ȱ¿ëÇÒ »Ó¸¸ ¾Æ´Ï¶ó »õ·Î¿î µµÀü¿¡ ´ëÀÀÇϱâ À§ÇÑ ±â¼ú Çõ½ÅÀ» ÃËÁøÇϱâ À§ÇØ ÀÌ·¯ÇÑ ºÐ¾ß¿¡ ÃÊÁ¡À» ¸ÂÃâ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±âȸ¸¦ ÀνÄÇÏ´Â °ÍÀº ÇöÀç ¿ªµ¿ÀûÀ¸·Î ¿òÁ÷À̰í ÀÖ´Â À¯ÀüÇÐ ºÐ¾ß¿¡¼­ À¯ÀÍÇÑ ¿¬±¸¸¦ ¼öÇàÇÏ´Â µ¥ Áß¿äÇÕ´Ï´Ù.

Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀå ÃËÁø¿äÀÎ ¹× °úÁ¦

Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀåÀÇ ¼ºÀå°ú °³Ã´Àº ´Ù¾çÇÑ ÃËÁø¿äÀÎ ¹× °úÁ¦¿¡ ÀÇÇØ ¿µÇâÀ» ¹Þ½À´Ï´Ù. ±â¼ú ¹ßÀü, ±ÔÁ¦ º¯È­, °æÁ¦Àû ¿äÀÎ, À±¸®Àû °í·Á»çÇ× µîÀÌ ½ÃÀåÀ» Çü¼ºÇÕ´Ï´Ù. ÀÌÇØ°ü°èÀÚµéÀº ÀÌ·¯ÇÑ ÃËÁø¿äÀΰú °úÁ¦¸¦ ÀÌÇØÇÏ´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù. ±×·¡¾ß¸¸ º¯È­Çϴ ȯ°æ ¼Ó¿¡¼­ ±âȸ¸¦ Ȱ¿ëÇϰí ÀáÀçÀûÀÎ À庮À» °ü¸®ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ±âȸ¸¦ Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀåÀ» ÁÖµµÇÏ´Â ¿äÀÎÀº ´ÙÀ½°ú °°½À´Ï´Ù.

1. ±â¼ú ¹ßÀü : CRISPR/Cas9¸¦ ºñ·ÔÇÑ °í¼Ó À¯ÀüÀÚ ÆíÁý ±â¼úÀº Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀåÀÇ ¼ºÀå ¼Óµµ¸¦ ³ôÀÌ´Â Áß¿äÇÑ ¿äÀÎÀÔ´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â Á¤È®ÇÑ À¯ÀüÀÚ º¯ÇüÀ» °¡´ÉÇÏ°Ô ÇÏ¿© ¿¬±¸, ³ó¾÷ ¹× ±âŸ ÀÇ·á ºÐ¾ß¿¡¼­ ȹ±âÀûÀÎ ¹ßÀüÀ» °¡Á®¿Ô½À´Ï´Ù. À¯ÀüÀÚ ÆíÁý µµ±¸ÀÇ Áö¼ÓÀûÀÎ °³¼±Àº Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ßÀÇ ´É·ÂÀ» È®ÀåÇÏ°í ½ÃÀåÀÇ ¼ºÀåÀ» ¸ñ°ÝÇÏ°í °ü½ÉÀ» °¡Áø ÅõÀÚÀÚµéÀ» ²ø¾îµéÀ̰í ÀÖ½À´Ï´Ù.

2. ¿¬±¸°³¹ß Ȱµ¿ÀÇ Áõ°¡ : »ý¸í°øÇÐ ºÐ¾ß ¹× Á¦¾àȸ»ç µî ´Ù¾çÇÑ ºÐ¾ßÀÇ ¿¬±¸°³¹ß ÅõÀÚ Áõ°¡°¡ Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿¬±¸°³¹ß Ȱµ¿ÀÌ È°¹ßÇØÁö¸é¼­ »õ·Î¿î ÀÀ¿ë ºÐ¾ß¿Í Á¦Ç°ÀÌ °³¹ßµÇ¾î ½ÃÀå È®´ë¿Í ±â¼ú Çõ½Å¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. À¯ÀüÀÚ ¿¬±¸¿Í ±â¼úÀº °ø°ø ¹× ¹Î°£ ÀÚ±Ý Áö¿øÀ¸·Î ¹ßÀüÇϰí ÀÖ½À´Ï´Ù.

3. ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ : Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¸ÂÃãÇü ÀÇ·á·ÎÀÇ Àüȯ¿¡ µû¸¥ °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº À¯ÀüÀÚ ÇÁ·ÎÆÄÀÏ¿¡ ±â¹ÝÇÑ ¸ÂÃãÇü Ä¡·á¸¦ Á¦°øÇÏ¿© Ç¥ÀûÄ¡·á ¹× Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ Á¢±ÙÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. °³ÀÎ ¸ÂÃãÇü ÀÇ·áÀÇ Ãß¼¼¿¡ µû¶ó Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ¼Ö·ç¼Ç ½ÃÀåÀº ƯÈ÷ ÀÇ·á ºÐ¾ß¿¡¼­ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

4. »ý¸í°øÇÐ ÀÀ¿ë È®´ë : ³ó¾÷»ý¸í°øÇÐ, Àç»ýÀÇ·á, ȯ°æ°ü¸® µî »ý¸í°øÇÐ ÀÀ¿ë ºÐ¾ßÀÇ È®´ë°¡ Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. »ý¸í°øÇÐÀÇ ¹ßÀüÀº Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ßÀÇ ´Ù¾çÇÑ ÀÀ¿ë ºÐ¾ß¸¦ âÃâÇÏ¿© ´Ù¾çÇÑ ºÐ¾ßÀÇ ±â¼ú Çõ½Å°ú ÇÔ²² ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀÔ´Ï´Ù.

5. Çù¾÷ ¹× ÆÄÆ®³Ê½Ê Áõ°¡ : »ý¸í°øÇÐ ±â¾÷, ¿¬±¸±â°ü, Çмú±â°ü µî °£ÀÇ Çù·Â°ü°è °­È­·Î Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ±â¼ú ¿¬±¸°¡ ÃËÁøµÉ °ÍÀÓ. °øµ¿ ¿¬±¸´Â ¿¬±¸ ´É·ÂÀ» Çâ»ó½Ã۰í, °³¹ß ÇÁ·Î¼¼½º¸¦ °¡¼ÓÈ­Çϸç, Çõ½ÅÀûÀÎ Á¦Ç°À» »ý»êÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. °á°úÀûÀ¸·Î ÀÌ·¯ÇÑ ÆÄÆ®³Ê½ÊÀº ½ÃÀå ³» ±â¼ú ¹ßÀüÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù.

Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀåÀÇ °úÁ¦´Â ´ÙÀ½°ú °°½À´Ï´Ù.

1. À±¸®Àû, ±ÔÁ¦Àû ¹®Á¦ : Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ßÀ» µÑ·¯½Ñ À±¸®Àû ¹®Á¦¿Í ±ÔÁ¦Àû °úÁ¦°¡ °áÇյǾî ÀÌ ºÎ¹®ÀÇ ½ÃÀå ±Ô¸ð°¡ »ó´çÈ÷ Á¦ÇѵǾî ÀÖ½À´Ï´Ù. À¯ÀüÀÚ º¯ÇüÀÇ ¾ÈÀü¼º, À¯È¿¼º, À±¸®Àû ÇÔÀÇ¿¡ ´ëÇÑ ¹®Á¦¸¦ °í·ÁÇÏ´Â µ¿½Ã¿¡ ÀÌ·¯ÇÑ ¹®Á¦¿¡ ´ëÇØ ±ÔÁ¤µÈ ±ÔÁ¦¸¦ ÁؼöÇØ¾ß ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿ì·Á¸¦ ÇØ°áÇØ¾ß¸¸ ´ëÁßÀÌ ¹Þ¾ÆµéÀÏ ¼ö Àִ åÀÓ°¨ ÀÖ´Â ±â¼ú »ç¿ëÀ» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

2. ³ôÀº ±â¼ú °³¹ß ºñ¿ë : °íµµÀÇ º¹Á¦ ±â¼úÀ̳ª µ¹¿¬º¯ÀÌÀ¯¹ß ±â¼úÀ» °³¹ß ¹× µµÀÔÇÒ ¶§ ¹ß»ýÇÏ´Â °íºñ¿ëÀº ½ÃÀå °³Ã´ÀÇ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌÇØ°ü°èÀÚº°·Î °í°¡ÀÇ Àåºñ¿¡ ´ëÇÑ Á¢±ÙÀÌ ¾î·Á¿ï ¼ö ÀÖ°í, ¿¬±¸°³¹ß ºñ¿ëÀ¸·Î ÀÎÇØ ¼Ö·ç¼Ç¿¡ Á¢±ÙÇϱ⠾î·Á¿î °æ¿ìµµ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àå¾Ö¹°À» ±Øº¹Çϱâ À§Çؼ­´Â ºñ¿ë °ü¸®¿Í ÀÚ±Ý Á¶´ÞÀ» È®º¸ÇØ¾ß ÇÕ´Ï´Ù.

3. ½ÃÀå °æÀï°ú Æ÷È­ : ±â¾÷ÀÌ Â÷º°È­¸¦ ÀÌ·ç°í ½ÃÀå Á¡À¯À²À» À¯ÁöÇϱâ À§Çؼ­´Â º¹Á¦ ¹× µ¹¿¬º¯ÀÌ À¯µµ ºÐ¾ßÀÇ Ä¡¿­ÇÑ °æÀï°ú ½ÃÀå Æ÷È­¿¡ ´ëÀÀÇØ¾ß ÇÕ´Ï´Ù. ¸¹Àº ±â¾÷ÀÌ Á¸ÀçÇÏ°í ±â¼ú Çõ½ÅÀÇ ¼Óµµ°¡ ºü¸£±â ¶§¹®¿¡ ±â¾÷Àº ²÷ÀÓ¾øÀÌ Çõ½ÅÇÏ°í °æÀï ȯ°æ¿¡¼­ ½Â¸®Çϱâ À§ÇØ Àü·«Àû Æ÷Áö¼Å´×À» ÃëÇØ¾ß ÇÕ´Ï´Ù.

±âŸ ¿äÀÎÀ¸·Î´Â ±â¼ú ¹ßÀü, ¿¬±¸ Ȱµ¿ÀÇ È°¼ºÈ­, °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, »ý¸í°øÇÐ ÀÀ¿ë È®´ë, °øµ¿ ¿¬±¸ °­È­ µîÀÌ Å¬·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. µµÀü°úÁ¦´Â À±¸®Àû °í·Á¿Í ±ÔÁ¦ ¹®Á¦, ±â¼ú °³Ã´¿¡ µû¸¥ ³ôÀº ºñ¿ë, ½ÃÀå °æÀï µîÀÌ ÀÖ½À´Ï´Ù. µû¶ó¼­ ÀÌÇØ°ü°èÀÚµéÀÌ ÀÌ·¯ÇÑ ÃËÁø¿äÀΰú °úÁ¦¸¦ ÀÌÇØÇϰí, ÀÌ¿ë °¡´ÉÇÑ ±âȸ¸¦ Ȱ¿ëÇÏ¿© ½ÃÀåÀ» ´õ ¸¹ÀÌ °³Ã´ÇÒ ¼ö ÀÖ´Â ±âȸ¸¦ Á¦°øÇÏ´Â °ÍÀÌ °¡Àå Áß¿äÇÕ´Ï´Ù.

ºÎ¹®º° Ŭ·Î´×°ú µ¹¿¬º¯ÀÌÀ¯¹ß

ÀÌ º¸°í¼­´Â Àü ¼¼°è Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß¿¡ ´ëÇÑ Á¦Ç°º°, ±â¼úº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ¿¹ÃøÀ» ´ã°í ÀÖ½À´Ï´Ù.

Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀåÀÇ ±¹°¡º° Àü¸Á

Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀåÀº ±Þ¼ÓÇÑ ±â¼ú ¹ßÀü°ú ¿¬±¸ ¹× ³ó¾÷ ºÐ¾ßÀÇ ÀÀ¿ë ºÐ¾ß°¡ Áõ°¡ÇÔ¿¡ µû¶ó »ó´çÇÑ ÁøÀüÀ» º¸À̰í ÀÖ½À´Ï´Ù. À¯ÀüÀÚ ¿¬±¸, »ý¸í°øÇÐ ¹× ³ó¾÷Àº ¸ðµÎ À¯ÀüÀÚ ±â´É ¿¬±¸, ÀÛ¹° ÇüÁú °³¼± ¹× À¯ÀüÀÚ º¯Çü »ý¹°ÀÇ »ý¼ºÀ» À§ÇØ À¯Àü ¹°ÁúÀ» Á¶ÀÛÇÏ´Â Áß¿äÇÑ ±â¼ú·Î Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ßÀ» Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. ÃÖ±Ù Ãß¼¼´Â À¯Àü°øÇÐÀÇ Çõ½Å, »õ·Î¿î ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, »ý¸í°øÇп¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¹Ì±¹, Áß±¹, µ¶ÀÏ, Àεµ, ÀϺ» µî °¢ Áö¿ªÀÇ ÀÌ·¯ÇÑ ±â¼ú °³¹ßÀº ±â¼ú °³¹ß ¹æÇâ°ú ¹Ì·¡ ¿¬±¸¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.

ÀÚÁÖ ¹¯´Â Áú¹®

Q1. Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀå ±Ô¸ð´Â?

A1. ¼¼°è Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀåÀº 2030³â±îÁö ¾à 70¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Q2. Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀåÀÇ ¼ºÀå Àü¸ÁÀº?

A2. ¼¼°è Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 18.0%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Q3. Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀåÀÇ ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?

A3. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ¸¸¼ºÁúȯ ¹× À¯Àü¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ±â¼ú äÅà Ȯ´ë, °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù.

Q4. ½ÃÀåÀÇ ÁÖ¿ä ºÎ¹®Àº?

A4. Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀåÀÇ ¹Ì·¡´Â ¹ÙÀÌ¿ÀÀǾàǰ ¹× Á¦¾àȸ»ç, CRO ¹× CMO, Çмú ¹× ¿¬±¸±â°ü ½ÃÀå¿¡ ±âȸ°¡ ÀÖ¾î À¯¸ÁÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

Q5. ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº?

A5. Ŭ·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ßÀÇ ÁÖ¿ä ±â¾÷Àº ´ÙÀ½°ú °°½À´Ï´Ù.

Q6. ÇâÈÄ °¡Àå Å« ½ÃÀå ºÎ¹®Àº?

A6. LucintelÀº À¯ÀüÀÚ Ä¡·á, À¯ÀüÀÚ ºÐ¼®, ¹ÙÀÌ¿ÀÀǾàǰ µî ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ Ŭ·Ð ŰƮ°¡ äÅõǰí Àֱ⠶§¹®¿¡ ¿¹Ãø ±â°£ µ¿¾È¿¡µµ Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù.

Q7. ½ÃÀå¿¡¼­ ÇâÈÄ 5³â°£ °¡Àå Å« ½ÃÀåÀÌ µÉ °ÍÀ¸·Î ¿¹»óµÇ´Â Áö¿ªÀº?

A7. ºÏ¹Ì´Â »ý¸í°øÇÐ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ÁÖ¿ä ±â¾÷ÀÇ Á¸Àç·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« Áö¿ªÀ¸·Î ³²À» °ÍÀÔ´Ï´Ù.

Q8. º¸°í¼­ »ç¿ëÀÚ Á¤Àǰ¡ °¡´ÉÇմϱî?

A8. ¿¹, LucintelÀº Ãß°¡ ºñ¿ë¾øÀÌ 10%ÀÇ »ç¿ëÀÚ Á¤ÀǸ¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ Å¬·Î´× ¹× µ¹¿¬º¯ÀÌÀ¯¹ß ½ÃÀå : ½ÃÀå ¿ªÇÐ

Á¦3Àå 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®

Á¦4Àå 2018³âºÎÅÍ 2030³â±îÁö Áö¿ªº° ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®

Á¦5Àå °æÀï ºÐ¼®

Á¦6Àå ¼ºÀå ±âȸ¿Í Àü·« ºÐ¼®

Á¦7Àå ÁÖ¿ä ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Cloning and Mutagenesis Trends and Forecast

The future of the global cloning and mutagenesis market looks promising with opportunities in the biopharmaceutical & pharmaceutical company, CROs & CMOs, and academic & research institute markets. The global cloning and mutagenesis market is expected to reach an estimated $7 billion by 2030 with a CAGR of 18.0% from 2024 to 2030. The major drivers for this market are increasing prevalence of chronic diseases and genetic disorders, growing adoption of cloning and mutagenesis technologies, and rising demand for personalized medicine.

Lucintel forecasts that cloning kits will remain the larger segment over the forecast period due to its increasing adoption in a wide range of applications, such as gene therapy, gene analysis, and biopharmaceuticals.

Within this market, biopharmaceutical & pharmaceutical companies will remain the largest segment due to increasing prevalence of diseases.

North America will remain the largest region over the forecast period due to increasing demand for biotechnology techniques and presence of key players in the region.

Emerging Trends in the Cloning and Mutagenesis Market

Cloning researches and their commercialization are changing fast due to advances in technology, shifts in market demands, and regulations that alter these trends. These are some of the areas that determine what direction cloning/mutagenesis takes for purposes of research or development. Understanding these trends allows any interested party to have a clearer picture concerning where the market is headed towards in future as well as its challenges.

Cloning and mutagenesis market is undergoing tremendous change with trends such as increasing gene-editing technologies, integration of AI & machine learning, personalized medicine growth; more focus on ethical issues as well as regulation control; expanding into the developing world. These trends are redefining how cloning & mutagenesis evolve while driving innovation, expanding application options and influencing market dynamics. It is therefore important that key stakeholders keep track of them so that they can use them as avenues for exploiting new opportunities in the ever changing field of genetics research and bio technology.

Recent Developments in the Cloning and Mutagenesis Market

Recent developments have marked significant technological advances within the cloning and mutagenesis space which have been accompanied by evolving regulatory frameworks leading to increased adoption across different industries. As a result, this changes how genetic research has come a long way from simpler times when cloning was just an academic exercise we read about. Thus understanding these developments tells us what might be responsible for what drives the present state of the market.

Advancements in gene-editing tools, synthetic biology developments, growing use of genomic databases, emerging regulatory frameworks, opportunities for collaboration among others are some of the recent trends in the cloning and mutagenesis market that will shape its future direction as well as influence genetic research activities. These developments have broadened the scope of applications possible with cloning and mutagenesis technologies thereby driving innovation while impacting on market dynamics.

Strategic Growth Opportunities for Cloning and Mutagenesis Market

Technological advancements, increased applications, as well as shifting market needs drive strategic growth opportunities in cloning and mutagenesis industry. Recognizing such prospects can help them enlarge their territories thus promoting innovations hence addressing an array of hitches. By focusing on top niche areas plus trends; businesses as well as researchers can bank upon exponential possibilities within cloning and mutagenesis field.

Strategic growth opportunities in the cloning and mutagenesis market include agricultural biotechnology, personalized medicine, regenerative medicine, drug development and discovery, and environmental and industrial applications. Stakeholders can focus on these areas to drive innovation towards addressing emerging challenges as well as take advantage of a growth opportunity in cloning and mutagenesis. Appreciating these opportunities will be instrumental to fruitful researches in genetics field that is currently dynamic.

Cloning and Mutagenesis Market Driver and Challenges

Cloning and Mutagenesis Market Driver and Challenges

The growth and development of the cloning and mutagenesis market is influenced by various drivers and challenges. Technological advancements, regulatory changes, economic factors as well as ethical considerations shape the market. It is important for stakeholders to understand these drivers and challenges so that they navigate through this changing landscape while capitalizing on opportunities but also managing potential barriers.

The factors responsible for driving the cloning and mutagenesis market include:

1. Technological Advancements: Fast gene-editing technologies including CRISPR/Cas9 amongst others are key factor driving cloning & mutagenesis markets' expansion rate. These tools enable precise genetic modifications leading to breakthroughs made within research works, agriculture among other medical fields. Continuous improvement of gene editing tools expands capabilities of cloning & mutagenesis making it grow thus attracting investors who have interest since they witness a growing market.

2. Increasing Research And Development Activities: Increased investments in R&D across various sectors such as biotech sector, pharmaceutical companies among others is fueling demand of cloning & mutagenesis. More R&D activities lead to new applications and products being developed, thereby contributing to the expansion of the market and innovation. Genetic research and technology are advanced through funding from public and private sources.

3. Growing Demand for Personalized Medicine: The increasing demand for cloning & mutagenesis technologies is driven by a shift towards personalized medicine. These technologies offer individualized treatment based on their genetic profiles leading to targeted therapies and precision medicine approaches. Owing to the trend of personalized medicine, there has been an increased market for cloning & mutagenesis solutions especially in the health sector.

4. Expansion of Biotechnology Applications: The growth of cloning and mutagenesis market is driven by expanding biotech applications such as agricultural biotech, regenerative medicine and environmental management among others. Biotechnology developments create diverse applications for cloning and mutagenesis hence fostering market growth together with innovation in different fields.

5. Increasing Collaboration And Partnerships: Enhancements in cloning and mutagenesis technologies are facilitated by increased collaborations between biotech firms, research institutions, academic organizations etc. Collaborative efforts help improve research capabilities speed up development process as well as result in innovative products. Consequently these partnerships foster technological advancements within markets.

Challenges in the cloning and mutagenesis market are:

1. Ethical And Regulatory Concerns: Ethical issues combined with regulatory challenges surrounding cloning & mutagenesis restricts market size of this subsector considerably. Issues concerning safety, efficacy or ethical implications of genetic modifications ought to be taken into account while at the same time conforming to regulations laid down regarding such issues. It is necessary that these concerns are addressed so as to ensure responsible use of technologies in order gain public acceptance.

2. High Costs of Technology Development: The high expenses incurred in developing and implementing advanced cloning and mutagenesis technologies can hinder market growth. Some stakeholders may face difficulties accessing expensive equipment while the cost of research and development may make solutions unaffordable. Overcoming this obstacle requires managing costs as well as securing financing.

3. Market Competition and Saturation : For companies to differentiate themselves and maintain their market shares, they must deal with intense competition and market saturation in the cloning and mutagenesis sector. It is necessary for firms to keep on innovating due to presence of many players and fast changing technologies, thus strategically positioning themselves in order to excel in a competitive environment.

Such factors include technological advancements, increased research activities, rising demand for personalized medicine, expansion of biotechnology applications, and enhanced collaboration among others are driving the cloning and mutagenesis market. Challenges encompass ethical considerations as well as regulatory issues, high costs associated with technology development as well as market competition. Hence it is paramount that stakeholders comprehend these drivers plus challenges providing them an opportunity to exploit the market further by taking advantage of such opportunities available.

List of Cloning and Mutagenesis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cloning and mutagenesis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cloning and mutagenesis companies profiled in this report include-

Cloning and Mutagenesis by Segment

The study includes a forecast for the global cloning and mutagenesis by product, technology, end use, and region.

Cloning and Mutagenesis Market by Product [Analysis by Value from 2018 to 2030]:

Cloning and Mutagenesis Market by Technology [Analysis by Value from 2018 to 2030]:

Cloning and Mutagenesis Market by End Use [Analysis by Value from 2018 to 2030]:

Cloning and Mutagenesis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

Country Wise Outlook for the Cloning and Mutagenesis Market

The market for cloning and mutagenesis has been witnessing significant advancements due to swift technological progress and increased applications in research and agriculture. Genetic research, biotechnology, and agriculture all use cloning and mutagenesis as vital techniques that entail manipulating genetic material for study of gene function, crop trait improvement or creation of genetically modified organisms. Recent developments have been driven by innovations in genetic engineering, emerging regulatory frameworks, and increased investments in biotechnology. The development of each region United States, China, Germany, India and Japan in these technologies has influenced the direction of technology development as well as future research.

Features of the Global Cloning and Mutagenesis Market

Market Size Estimates: Cloning and mutagenesis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cloning and mutagenesis market size by product, technology, end use, and region in terms of value ($B).

Regional Analysis: Cloning and mutagenesis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, technologies, end uses, and regions for the cloning and mutagenesis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cloning and mutagenesis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q.1 What is the cloning and mutagenesis market size?

Answer: The global cloning and mutagenesis market is expected to reach an estimated $7 billion by 2030.

Q.2 What is the growth forecast for cloning and mutagenesis market?

Answer: The global cloning and mutagenesis market is expected to grow with a CAGR of 18.0% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the cloning and mutagenesis market?

Answer: The major drivers for this market are increasing prevalence of chronic diseases and genetic disorders, growing adoption of cloning and mutagenesis technologies, and rising demand for personalized medicine.

Q4. What are the major segments for cloning and mutagenesis market?

Answer: The future of the cloning and mutagenesis market looks promising with opportunities in the biopharmaceutical & pharmaceutical company, CROs & CMOs, and academic & research institute markets.

Q5. Who are the key cloning and mutagenesis market companies?

Answer: Some of the key cloning and mutagenesis companies are as follows:

Q6. Which cloning and mutagenesis market segment will be the largest in future?

Answer: Lucintel forecasts that cloning kits will remain the larger segment over the forecast period due to its increasing adoption in a wide range of applications, such as gene therapy, gene analysis, and biopharmaceuticals.

Q7. In cloning and mutagenesis market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing demand for biotechnology techniques and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Table of Contents

1. Executive Summary

2. Global Cloning and Mutagenesis Market : Market Dynamics

3. Market Trends and Forecast Analysis from 2018 to 2030

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

5. Competitor Analysis

6. Growth Opportunities and Strategic Analysis

7. Company Profiles of Leading Players

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â